No Data
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Morgan Stanley: Personalized cancer vaccines and ADCs will become the main catalysts in the oncology treatment Industry by 2025.
Morgan Stanley stated in a recent research report that personalized cancer vaccines and antibody-drug conjugates (ADCs) will become one of the major innovations in cancer biotechnology next year.
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Weekly Buzz: So far, Santa is Letting us Down
Moderna Options Spot-On: On December 27th, 138.19K Contracts Were Traded, With 648.69K Open Interest
Unusual Options Activity: ANET, MSTR and Others Attract Market Bets, ANET V/OI Ratio Reaches 138.7